NCT02325856View on ClinicalTrials.gov

Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients

NACompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Fluid Overload
Interventions
DEVICE

Bioimpedance Spectroscopy

Bioimpedance Spectroscopy is a safe tool to evaluate the fluid status in hemodialysis patients.

BEHAVIORAL

Clinical judgement

All Listed Sponsors
collaborator

Nephrocare AsiaPacific

UNKNOWN

lead

An Hsin QingShui Clinic

OTHER

NCT02325856 - Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients | Biotech Hunter | Biotech Hunter